Kamran Shahid

5PUBLICATIONS
5CO-AUTHORS
Toxicology (incl. clinical toxicology)Gene and molecular therapyNeural engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 12, 2026
Advancing hypoparathyroidism treatment: FDA approval of Palopegteriparatide as a promising orphan drug.

Syeda Rabiah Shahid, Kamran Shahid, Sikandar Ehsan

|Jan 07, 2026
FDA approval of prademagene zamikeracel (Zevaskyn): advancing gene therapy for recessive dystrophic epidermolysis bullosa (RDEB) patients.

Syeda Rabiah Shahid, Kamran Shahid, Maliha Khalid

|Nov 03, 2025
Biologic relief without the price tag: the promise of omlcylo in atopic asthma and chronic spontaneous urticaria.

Anna Mumtaz, Kamran Shahid, Maliha Khalid

|Nov 03, 2025
Redefining uUTI therapy: Orlynvah as a promising oral alternative (sulopenem etzadroxil and probenecid).

Kamran Shahid, Syeda Rabiah Shahid, Maliha Khalid

|Aug 11, 2025
Breaking chains: IMAAVY redefines generalized myasthenia gravis treatment.

Kamran Shahid, Syeda Rabiah Shahid, Maliha Khalid

Pageof 1

Frequent Collaborators

5 joint publications

Maliha Khalid

5 joint publications

Aminath Waafira

4 joint publications

Syeda Rabiah Shahid

1 joint publications

Anna Mumtaz